Datametrex Announces Closing of First Tranche of Private

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
68
Datametrex Announces Closing of First Tranche of Private Placement

TORONTO, Jan. 25, 2019 (GLOBE NEWSWIRE) -- Datametrex AI Limited (the “ Company ” or “ Datametrex ”) ( TSXV: DM, FSE: D4G ) is pleased to announce the completion of the first tranche of its previously-announced non-brokered private placement (the “ Offering ”) of units (each a “ Unit ”) at a price of $0.05 per Unit (the “ Offering ”). An aggregate of 22,044,000 Units were sold under the first tranche for aggregate gross proceeds of $1,102,200. The Company intends to close additional tranches with the last tranche to be completed no later than February 7, 2019.  The Offering is for a maximum of up to 30,000,000 Units for aggregate proceeds of up to $1,500,000. The Company may, at its sole discretion, increase the size of the Offering by up to 20% (an additional 6,000,000 Units for an aggregate of 36,000,000 Units) before closing of the final tranche of the Offering.     

Each Unit consisted of one common share in the capital of the Company and one common share purchase warrant, with each warrant exercisable into one common share at a price of $0.08 for a period of 18 months after closing of the Offering (the “ Warrant Expiry Date ”). In the event that the volume-weighted average trading price of the common shares on the TSX Venture Exchange equals or exceeds $0.12 per common share for any period of 15 consecutive trading days, the Company may, at its option, within 10 business days following such 15-day period, accelerate the Warrant Expiry Date by issuing a press release (a “ Warrant Acceleration Press Release ”), and, in such case, the Warrant Expiry Date shall be deemed to be 5:00 p.m. (Toronto time) on the 15th day following the issuance of the Warrant Acceleration Press Release. The Company intends to use the aggregate net proceeds of the Offering for research and development and general working capital purposes.

Although the Offering is non-brokered, the Company compensated certain dealers that introduced subscribers to the Company (each a “ Finder ”) by way of: (i) a cash finder’s fee to each Finder equal to 8% of the aggregate gross proceeds of the subscribers introduced to the Company by such Finder; and (ii) non-transferable common share purchase warrants (on terms identical to those warrants under the Offering) to each Finder equal to the aggregate Units of the subscribers introduced to the Company by such Finder.

The securities issued in connection with this first tranche of the Offering, including the Finder’s warrants, are subject to a four-month hold period ending on May 26, 2019. Certain insiders of the Company participated in the first tranche of the Offering and purchased an aggregate of $545,000 (10,900,000 Units), which includes $300,000 (6 Million Units) from Andrew Ryu, CEO of the Company, and $120,000 (2.4 Million Units) from Jeffrey Stevens, President and COO of the Company. Participation of such insiders in the Offering constituted a “related party transaction” as defined under Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“ MI 61-101 ”), but is exempt from the formal valuation and minority shareholder approval requirements of MI 61-101, as neither the fair market value of the securities issued to the insider nor the consideration paid by the insider exceeded 25% of the Company’s market capitalization. None of the Company’s directors expressed any contrary views or disagreements with respect to the foregoing. The Company did not file a material change report 21 days prior to the closing of the Offering as the details of the participation of the insider of the Company had not been confirmed at that time.

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to four exciting verticals. Big Data, collecting data from retail point of sales environments. Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy ( www.nexalogy.com ). Implementing Blockchain technology for secure Data Transfers through its joint venture company, Graph Blockchain ( www.graphblockchain.com ). Industrial scale Cryptocurrency Mining through its wholly owned subsidiary, Ronin Blockchain Corp ( www.roninblockchain.com ). Additional information on Datametrex is available at: www.datametrex.com .

For further information, please contact:

Jeffrey Stevens – President & COO Phone: (647) 400-8494 Email: jstevens@datametrex.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains "forward-looking information" within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as "may", "will", "expect", "likely", "should", "would", "plan", "anticipate", "intend", "potential", "proposed", "estimate", "believe" or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions "may" or "will" happen, or by discussions of strategy.

The forward-looking information contained in this press release includes information relating to the closing of additional tranches of the Offering, the potential acceleration of the Warrant Expiry Date and the use of the net proceeds of the Offering. Forward-looking information is based upon certain material assumptions that were applied in drawing a conclusion or making a forecast or projection, including management's perceptions of historical trends, current conditions and expected future developments, as well as other considerations that are believed to be appropriate in the circumstances. While we consider these assumptions to be reasonable based on information currently available to management, there is no assurance that such expectations will prove to be correct.

By their nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this press release. Such factors include, without limitation, those discussed in the Company's current MD&A and Annual Information Form, both of which have been filed on SEDAR and can be accessed at www.sedar.com.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 322

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 174

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 175

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Off-Broadway Play 'DUST' Raises Autism Support Funds

Updated Category News Views 337

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

Continue Reading
JOYEE N01 Kicks Off Global Launch with African Orders

Updated Category News Views 296

A New Chapter for JOYEE N01 There's a moment in every company's life when it either steps boldly into the future or stumbles back into obscurity. For FAW Bestune, October 28, 2026, was one of those defining moments. On this day, they launched global mass production of the JOYEE N01 in Yancheng, China. And boy, did they pull out all the stops—you don't see this kind of...

Continue Reading
Paris Baguette Pioneers Drive-Thru in Oklahoma

Updated Category News Views 406

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

Continue Reading
Johnson & Johnson Unveils Promising PsA Treatment Data

Updated Category News Views 235

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...

Continue Reading
Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 317

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
Invasive Procedures Don't Extend Life in Stable Heart Disease

Updated Category News Views 280

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 165

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading

Top 5 Most Recently Viewed Articles

The Rise of Mycoplasma Testing: Future Growth and Trends

Updated Category News Views 102

Insights into the Growth of the Mycoplasma Testing Market The mycoplasma testing market is expected to balloon to USD 2.49 billion in the next few years. This impressive growth stems largely from the increasing use of cell culture techniques within biopharmaceutical research and development. As researchers and companies adopt these advanced methods, the demand for...

Continue Reading
Investors Urged to Examine Claims Against Toronto-Dominion Bank

Updated Category News Views 65

Faruqi & Faruqi Investigates Toronto-Dominion Bank Faruqi & Faruqi, LLP, a prominent national securities law firm, is currently investigating potential claims on behalf of investors who have suffered significant financial losses from their investments in The Toronto-Dominion Bank (NYSE: TD). The firm is reaching out to investors who experienced losses exceeding $100,000,...

Continue Reading
Heifer International Advocates for Farmer Support Amidst Crisis

Updated Category News Views 403

Heifer International Advocates for Farmer Support Amid Climate Crisis Heifer International is calling for urgent action to assist smallholder farmers affected by the extreme weather patterns brought on by climate change. The recent impact of Tropical Depression Sara highlights the vulnerability of agricultural communities across Central America, prompting the organization...

Continue Reading
Mitsubishi Tanabe Pharma Unveils RADICAVA ORS Insights at NASP

Updated Category News Views 135

Mitsubishi Tanabe Pharma America Unveils Data on RADICAVA ORS Mitsubishi Tanabe Pharma America, Inc. (MTPA) is thrilled to share vital information regarding their innovative product, RADICAVA ORS (edaravone), at an upcoming event designed for specialized pharmacy professionals. This presentation aims at enhancing the understanding of it’s application in managing...

Continue Reading
Warren Buffett's Coca-Cola Dividend Strategy: A Love Affair

Updated Category News Views 593

Warren Buffett's Love for Coca-Cola Warren Buffett, a legendary investor, is set to receive a staggering $776 million in dividends from Coca-Cola. This immense wealth from his investment in Coca-Cola illustrates the power of dividends in wealth accumulation. Buffett's investment journey with Coca-Cola has not only been fruitful financially but has also created a personal...

Continue Reading